Levitra Clinical Trial

Levitra is the first FDA approved impotence alternative to Viagra in five years. The efficacy of Levitra was evaluated in more than 50 clinical trials. The research involved 4,400 men with erectile dysfunction (ED). The prescription was assessed for the percentage of men who achieved results and the rate of speed.

The conclusions of the clinical research indicated the following:

1. For first time user, Levitra provided success and reliable improvement of the erectile function.
2. Eighty-five percent of the men from a diverse patient population achieved an improvement in their erections.
3. The male subjects reported harder erections and an improved sexual experience.

According to Dr. Myron Murdock, a specialist in the field of male sexual dysfunction, "In clinical trials, Levitra was shown to work quickly. More importantly, Levitra was shown to improve the sexual response for the majority of men the first time they took it, and it worked consistently over time." Furthermore, Levitra clinically demonstrated enhancing powering in men who had other medical factors, such as diabetes or prostate surgery.

In another study of Levitra, 463 men were evaluated for 12 weeks. The findings verified that men were three times more likely to complete sexual intercourse on Levitra than on a placebo. Approximately, 46 percent of the men using Levitra were sexually responsive compared with 10 percent on placebo.